OTCPK:ODYY

Stock Analysis Report

Odyssey Group International

Executive Summary

Odyssey Group International, Inc. engages in selling, marketing, and distributing of medical devices.

Snowflake

Fundamentals

Worrying balance sheet with weak fundamentals.

Risks

  • Odyssey Group International has significant price volatility in the past 3 months.
  • Odyssey Group International is not covered by any analysts.

Similar Companies

Share Price & News

How has Odyssey Group International's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

38.9%

ODYY

-0.04%

US Healthcare

-0.6%

US Market


1 Year Return

n/a

ODYY

-9.1%

US Healthcare

0.7%

US Market

No trading data on ODYY.

No trading data on ODYY.


Share holder returns

ODYYIndustryMarket
7 Day38.9%-0.04%-0.6%
30 Day0%1.0%2.9%
90 Dayn/a-1.5%1.3%
1 Yearn/a-7.7%-9.1%2.9%0.7%
3 Yearn/a29.6%24.3%44.6%35.2%
5 Yearn/a66.1%56.2%61.9%44.2%

Price Volatility Vs. Market

How volatile is Odyssey Group International's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Odyssey Group International undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Odyssey Group International is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Odyssey Group International has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of ODYY’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Odyssey Group International regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Odyssey Group International expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

11.1%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Odyssey Group International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of ODYY’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Odyssey Group International's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Odyssey Group International performed over the past 5 years?

-23.4%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Odyssey Group International does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Odyssey Group International's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Odyssey Group International's 1-year growth to the US Healthcare industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Odyssey Group International has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

It is difficult to establish if Odyssey Group International has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Odyssey Group International improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.


Next Steps

Financial Health

How is Odyssey Group International's financial position?


Financial Position Analysis

Odyssey Group International's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

Odyssey Group International has no long term commitments.


Debt to Equity History and Analysis

Odyssey Group International has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if Odyssey Group International's debt level has increased considering it has negative shareholder equity.


Balance Sheet

Low level of unsold assets.

Odyssey Group International has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Odyssey Group International has less than a year of cash runway based on current free cash flow.

Unable to confirm if Odyssey Group International has at least 1 year of cash runway based on growing free cash flows without relevant data.


Next Steps

Dividend

What is Odyssey Group International's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Odyssey Group International's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Odyssey Group International's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Odyssey Group International has not reported any payouts.

Unable to verify if Odyssey Group International's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Odyssey Group International has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Odyssey Group International's salary, the management and board of directors tenure and is there insider trading?

0.3yrs

Average board tenure


CEO

Joseph Redmond (58yo)

1.8yrs

Tenure

US$80,000

Compensation

Mr. Joseph Michael Redmond is Chairman, President and Chief Executive Officer of Odyssey Group International, Inc. since December 1, 2017 and also serves as Chief Financial Officer and Secretary. Mr. Redmo ...


CEO Compensation Analysis

Joseph's remuneration is lower than average for companies of similar size in United States of America.

Insufficient data for Joseph to compare compensation growth.


Board Age and Tenure

0.3yrs

Average Tenure

The average tenure for the Odyssey Group International board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Joseph Redmond (58yo)

    Chairman

    • Tenure: 1.8yrs
    • Compensation: US$80.00k

Board Members

  • Joseph Redmond (58yo)

    Chairman

    • Tenure: 1.8yrs
    • Compensation: US$80.00k
  • Jake Van Landingham

    Director

    • Tenure: 0.3yrs
  • Jeff Conroy

    Independent Director

    • Tenure: 0.08yrs

Company Information

Odyssey Group International, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Odyssey Group International, Inc.
  • Ticker: ODYY
  • Exchange: OTCPK
  • Founded: 2014
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: US$120.304m
  • Shares outstanding: 68.75m
  • Website: https://theodysseygroupinternational.com

Number of Employees


Location

  • Odyssey Group International, Inc.
  • 2372 Morse Avenue
  • Irvine
  • California
  • 92614
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ODYYOTCPK (Pink Sheets LLC)YesCommon StockUSUSDMar 2017

Biography

Odyssey Group International, Inc. engages in selling, marketing, and distributing of medical devices. Its product is CardioMap, a non-invasive testing for heart disease. The company was founded in 2014 and ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/22 00:41
End of Day Share Price2019/09/19 00:00
Earnings2019/04/30
Annual Earnings2018/07/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.